|Bid price||1.75||Open price||1.88|
|Ask price||2.00||Prev close||1.88|
Register now for FREE live Surgical Innovations Group share prices, Surgical Innovations Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Surgical Innovations Group Level 2 Data, indepth research tools and investor commentary for Surgical Innovations Group (SUN) and other London Stock Exchange equities.
Register now for FREE Surgical Innovations Group share price charts
|Name||Surgical Innovations Group||Epic||SUN|
|Sector||Health Care Equipment & Services||ISIN||GB0004016704|
|Activites||Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.||Index||n/a|
|Latest Share Price (p)||1.88||Net Gearing (%)||39.71|
|Market Capitalisation (£m)||9.12||Gross Gearing (%)||45.73|
|Shares in issue (m)||485.06||Debt Ratio||37.85|
|P/E Ratio||-0.86||Debt-to-Equity Ratio||0.72|
|Total dividends per share (p)||0.00||Assets / Equity Ratio||1.84|
|Dividend Yield (%)||0.00||Price to book value||1.49|
|Dividend cover (x)||0.00||ROCE||-0.92|
|Earning per share (p)||-2.19||EPS Growth (%)||-1,195.00|
|52 week high / low||5.88 / 1.05||DPS Growth (%)||n/a|
|Dec.Date||Type||Director||Pos||No. of Shares|
FTSE indices stepped lower in early deals with easyJet (EZJ) leading a squadron of sectors south as the post-election slide continues from yesterday. Pharma, financial and property stocks continued in focus. Wall St fell overnight, and Asian markets were softer. Shortly after the open, FTSE 100...
Surgical Innovations has widened its FY pretax loss to Â£9.8m, from Â£44,000. The results included Â£8.4m of exceptional items, of which Â£7.8m were non-cash impairment charges. Revenue was Â£4.0m, from Â£7.5m. Chairman Doug Liversidge commented: "The financial performance for 2014 was...
Story provided by StockMarketWire.com
Register now for FREE Surgical Innovations Group company news
As a new investor I am at a loss to know why this little gem never goes anywhere Is is a medical company with no debt, a profit!, minimal market capital and some interesting products. We're in the shares4 schools contest and we'd like this babe to fly!
Another risky one but with a new income stream things are looking up for Sun. Why they did not perform better last year is anyones guess. I suppose the big boys have been let down before but this time its different . Take a look - long term holder.....
I am at a loss both mentally and financially about the goings on here. The company is involved in health care and all it's peers have risen substantially. Debt has been cleared, profits are rising and the chairman's statement was incredibly positive. I always thought a star of this kind...
Register now for FREE Surgical Innovations Group share price discussions